|
|
|
|
||
Re: ppsBUZZ-Amarin Corp Plc: FDA rejects drug's expanded label 10:24 AM ET, 04/28/2015 - Reuters ** Irish drugmaker's U.S.-listed shares down 7.9 pct at $1.98 ** U.S. FDA rejects Amarin's application to expand the label of its drug Vascepa, citing insufficient data to show it reduces cardiovascular-related risks ** Company says it had been expecting the rejection; does not plan to appeal decision ** More than 1.9 mln shares traded, nearly equaling their 10-day average of 2.1 mln ** Vascepa is approved in the United States to reduce high levels of triglycerides in patients with hypertriglyceridemia ** Hypertriglyceridemia is often caused by uncontrolled diabetes, obesity, and sedentary habits and is a risk factor for coronary artery diseases ** Up to Monday's close, stock had more than doubled this year |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
1791 | Re: pps | ex_hacker202 | 5 | 4/28/2015 12:04:27 PM |